Monkeypox, more commonly known as mpox, is becoming a more serious worldwide health concern. But there is a glimmer of hope ...

With the clade 1 outbreak of mpox (formerly monkeypox) raging through the ... become markedly vulnerable to infection. While Bavarian Nordic’s vaccine Jynneos is approved in several countries ...

Danish pharmaceutical company Bavarian Nordic announced Wednesday that it has secured a contract to supply 440,000 doses of its monkeypox vaccine to “undisclosed European countries.” ...

A clinical trial by the US National Institutes of Health (NIH) has shown that Bavarian Nordic’s mpox vaccine induced an antibody response in adolescents equivalent to that of adults. The interim ...

The World Health Organization said on Monday it had approved Bavarian Nordic's mpox vaccine for adolescents aged 12 to 17 years, an age group considered especially vulnerable to outbreaks of the ...

COPENHAGEN, Denmark, September 26, 2024 – Bavarian Nordic A/S (OMX: BAVA) today announced an agreement with UNICEF for the supply of 1 million doses of the MVA-BN® mpox vaccine for countries in ...

COPENHAGEN, Denmark, October 29, 2024 - Bavarian Nordic A/S (OMX: BAVA) announced today the initiation of a clinical study of the MVA-BN ® mpox/smallpox vaccine in children 2 to 11 years of age.

China to Manage Mpox as Disease on Par With COVID-19 China plans to manage mpox in the same way it handles infectious diseases such as COVID-19 after detecting around 500 cases of the viral ...

The World Health Organization said on Monday, October 14 that it had approved Bavarian Nordic's mpox vaccine for adolescents aged 12 to 17 years, an age group considered especially vulnerable to ...

(Reuters) -The World Health Organization said on Monday it had approved Bavarian Nordic's mpox vaccine for adolescents aged 12 to 17 years, an age group considered especially vulnerable to ...